New Whitepaper: How DeLorean AI Helped Atlantic Dialysis Slash Hospitalizations, Boost Revenue, and Improve Adherence
In partnership with Constellation Kidney Group, DeLorean AI launched its Renal AI solution across 13 dialysis clinics operated by Atlantic Dialysis Management Services (ADMS). Over a four-month pilot, the results were clear: Predictive AI can dramatically improve outcomes in dialysis care.
Hospitalizations Down 18%
By leveraging patient-level predictions and actionable insights, ADMS achieved a sustained drop in general hospitalizations, even accounting for seasonal fluctuations.
Care interventions up 70%
Clinics delivered over 660 informed care measures during the pilot period—leading to increased patient support and 181K dollars in additional revenue.
98 hospitalizations avoided
Clinician action on Renal AI’s suggestions helped prevent 98 hospitalizations, protecting both patients and the system—saving an estimated 1.9 million dollars in avoidable hospitalization costs.
No-shows reduced by 13.5%
Improved treatment adherence added 22K dollars in maintained revenue, while also improving patient stability.
All told, Renal AI helped ADMS exceed its expected financial impact by nearly double—delivering over 227K dollars in savings during the pilot and setting the stage for over 1 million dollars in annualized value.
Read the full whitepaper to see how predictive AI is changing renal care: